Is SBTX or RYLD a better dividend investment in 2026?

SBTX currently yields 34.07% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: SBTX offers higher current income.

What is the dividend yield difference between SBTX and RYLD?

SBTX has a forward dividend yield of 34.07% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 21.68 percentage points.

Home › Compare › SBTX vs RYLD

SBTX vs RYLD: Dividend Comparison 2026

SBTX yields 34.07% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SBTX wins by $121.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

SBTX

● Live price

34.07%

Share price

$5.87

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$167.0K

Annual income

$24,647.82

Full SBTX calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — SBTX vs RYLD

📍 SBTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SBTX	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SBTX + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SBTX pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SBTX

Annual income on $10K today (after 15% tax)

$2,896.08/yr

After 10yr DRIP, annual income (after tax)

$20,950.65/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, SBTX beats the other by $18,670.11/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SBTX + RYLD for your $10,000?

SBTX: 50%RYLD: 50%

100% RYLD50/50100% SBTX

Portfolio after 10yr

$106.1K

Annual income

$13,665.40/yr

Blended yield

12.88%

📊

Analyst Conviction Gap

Where Wall Street is split right now

SBTX

Analyst Ratings

Hold

Consensus: Hold

Altman Z

-0.3

Piotroski

1/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SBTX buys

RYLD buys

No recent congressional trades found for SBTX or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSBTXRYLD

Forward yield	34.07% ✓	12.39%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$167.0K ✓	$45.3K
Annual income after 10y	$24,647.82 ✓	$2,682.98
Total dividends collected	$119.3K ✓	$19.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: SBTX vs RYLD ($10,000, DRIP)

Year	SBTX Portfolio	SBTX Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$14,107	$3,407.16	$11,939	$1,239.34	+$2.2K → SBTX
2	$19,587	$4,492.08	$14,158	$1,382.89	+$5.4K → SBTX
3	$26,787	$5,828.90	$16,682	$1,532.59	+$10.1K → SBTX
4	$36,112	$7,450.06	$19,537	$1,687.64	+$16.6K → SBTX
5	$48,026	$9,386.56	$22,752	$1,847.20	+$25.3K → SBTX
6	$63,055	$11,666.79	$26,355	$2,010.43	+$36.7K → SBTX
7	$81,784	$14,315.54	$30,376	$2,176.45	+$51.4K → SBTX
8	$104,862	$17,353.02	$34,847	$2,344.43	+$70.0K → SBTX
9	$132,997	$20,794.11	$39,800	$2,513.54	+$93.2K → SBTX
10	$166,954	$24,647.82	$45,269	$2,682.98	+$121.7K → SBTX

SBTX vs RYLD: Complete Analysis 2026

SBTX — Stock

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Full SBTX Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this SBTX vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SBTX vs SCHD SBTX vs JEPI SBTX vs O SBTX vs KO SBTX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.